Literature DB >> 25739822

Impact of Remnant Lipoprotein on Coronary Plaque Components.

Natsumi Matsuo1, Tetsuro Matsuoka, Sumire Onishi, Hiroyasu Yamamoto, Akinobu Kato, Yasunaka Makino, Shinji Kihara.   

Abstract

AIM: Intravascular ultrasound (IVUS) is a useful modality for visualizing atherosclerotic lesions in coronary arteries, not only for the degree of arterial luminal stenosis but also for the plaque composition within the vessel walls. We aimed to determine the relationship between the clinical parameters and coronary plaque characteristics evaluated by IVUS in patients with stable angina under medical treatment.
METHODS: Plaque measurements within the coronary arteries were collected by coronary angiography and iMAP-IVUS in 40 men with stable angina. The serum remnant-like cholesterol (RemL-C) was measured using homogeneous assays and serum adiponectin and omentin-1 levels were measured by enzyme-linked immunosorbent assays.
RESULTS: The iMAP-IVUS analysis of the coronary arteries demonstrated that the plaque cross-sectional area (CSA) was 11.0±3.5 mm(2). Plaque CSA positively correlated with body mass index and negatively correlated with the serum adiponectin levels. Both areal and volumetric analyses of the plaque characteristics demonstrated that the serum RemL-C level was a positive determinant for %Necrosis and the negative determinant for %Fibrosis of the plaques. Neither serum high-density lipoprotein cholesterol nor low-density lipoprotein cholesterol levels correlated with the proportion of any plaque components. Additionally, the RemL-C/triglyceride ratio positively correlated with %Lipid significantly in the areal analysis.
CONCLUSION: Elevation of the serum RemL-C levels in the patients with stable angina may link to coronary plaque vulnerability, which is characterized by high necrotic and low fibrotic components.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25739822     DOI: 10.5551/jat.26328

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  7 in total

1.  Impact of the triglyceride level on coronary plaque components in female patients with coronary artery disease treated with statins.

Authors:  Motoki Yamashita; Atsushi Iwata; Yuta Kato; Makito Futami; Satoshi Imaizumi; Takashi Kuwano; Amane Ike; Makoto Sugihara; Hiroaki Nishikawa; Bo Zhang; Shin'ichiro Yasunaga; Keijiro Saku; Shin-Ichiro Miura
Journal:  Heart Vessels       Date:  2018-04-25       Impact factor: 2.037

2.  Cystatin C-Adiponectin Complex in Plasma Associates with Coronary Plaque Instability.

Authors:  Akane Matsumoto; Hiroyasu Yamamoto; Tetsuro Matsuoka; Kento Kayama; Sumire Onishi; Natsumi Matsuo; Shinji Kihara
Journal:  J Atheroscler Thromb       Date:  2017-03-17       Impact factor: 4.928

Review 3.  Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.

Authors:  Sadao Takahashi
Journal:  J Atheroscler Thromb       Date:  2017-04-19       Impact factor: 4.928

4.  Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.

Authors:  Kohei Wakabayashi; Tsuyoshi Nozue; Shingo Yamamoto; Shinichi Tohyama; Kazuki Fukui; Shigeo Umezawa; Yuko Onishi; Tomoyuki Kunishima; Akira Sato; Shogo Miyake; Yoshihiro Morino; Takao Yamauchi; Toshiya Muramatsu; Kiyoshi Hibi; Mitsuyasu Terashima; Hiroshi Suzuki; Ichiro Michishita
Journal:  J Atheroscler Thromb       Date:  2016-03-31       Impact factor: 4.928

Review 5.  Postprandial Hyperlipidemia and Remnant Lipoproteins.

Authors:  Daisaku Masuda; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2016-11-08       Impact factor: 4.928

6.  Prognostic impact of estimated remnant-like particle cholesterol in patients with differing glycometabolic status: an observational cohort study from China.

Authors:  Qi Zhao; Ting-Yu Zhang; Yu-Jing Cheng; Yue Ma; Ying-Kai Xu; Jia-Qi Yang; Yu-Jie Zhou
Journal:  Lipids Health Dis       Date:  2020-07-31       Impact factor: 3.876

7.  Anti-Apo B-100 Autoantibody is a Marker of Unstable Coronary Plaque.

Authors:  Minami Imai; Mari Kawamura; Ikoi Kochi; Tetsuro Matsuoka; Shinji Kihara; Hiroyasu Yamamoto
Journal:  J Atheroscler Thromb       Date:  2020-11-15       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.